| abstract |
An EP2 agonist that may have an EP3 agonistic action has a nerve regeneration and / or protective action, and thus, for example, lower and upper motor neuron diseases, nerve root diseases, plexus diseases, thoracic outlet compression syndrome, peripheral neuropathy It is effective as a therapeutic agent for peripheral nervous system diseases such as neurofibromatosis and neuromuscular transmission diseases. In addition, an EP2 agonist having an EP3 agonistic action is a safe and effective nerve regeneration and / or protective agent that hardly affects the circulatory system. |